Abecarnil (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Abecarnil" in English language version.

refsWebsite

Global rank English rank

14nih.gov

4^th place

8doi.org

2^nd place

3semanticscholar.org

11^th place

8^th place

1harvard.edu

18^th place

17^th place

doi.org

Ozawa M, Nakada Y, Sugimachi K, Yabuuchi F, Akai T, Mizuta E, et al. (March 1994). "Pharmacological characterization of the novel anxiolytic beta-carboline abecarnil in rodents and primates". Japanese Journal of Pharmacology. 64 (3): 179–187. doi:10.1254/jjp.64.179. PMID 7912751.
Aufdembrinke B (1998). "Abecarnil, a new beta-carboline, in the treatment of anxiety disorders". The British Journal of Psychiatry. Supplement. 34 (34): 55–63. doi:10.1192/S0007125000293537. PMID 9829018. S2CID 24311570.
Pinna G, Galici R, Schneider HH, Stephens DN, Turski L (March 1997). "Alprazolam dependence prevented by substituting with the beta-carboline abecarnil". Proceedings of the National Academy of Sciences of the United States of America. 94 (6): 2719–2723. Bibcode:1997PNAS...94.2719P. doi:10.1073/pnas.94.6.2719. PMC 20156. PMID 9122263.
Jung ME, Wallis CJ, Gatch MB, Lal H (June 2000). "Abecarnil and alprazolam reverse anxiety-like behaviors induced by ethanol withdrawal". Alcohol. 21 (2): 161–168. doi:10.1016/S0741-8329(00)00079-3. PMID 10963939.
Duka T, Schütt B, Krause W, Dorow R, McDonald S, Fichte K (April 1993). "Human studies on abecarnil a new beta-carboline anxiolytic: safety, tolerability and preliminary pharmacological profile". British Journal of Clinical Pharmacology. 35 (4): 386–394. doi:10.1111/j.1365-2125.1993.tb04155.x. PMC 1381549. PMID 8097921.
Löscher W, Hönack D (April 1992). "Withdrawal precipitation by benzodiazepine receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant beta-carboline abecarnil". Naunyn-Schmiedeberg's Archives of Pharmacology. 345 (4): 452–460. doi:10.1007/BF00176624. PMID 1352384. S2CID 20486955.
Sannerud CA, Ator NA, Griffiths RR (October 1992). "Behavioral pharmacology of abecarnil in baboons: self-injection, drug discrimination and physical dependence". Behavioural Pharmacology. 3 (5): 507–516. doi:10.1097/00008877-199210000-00009. PMID 11224153. S2CID 32081258.
Maleeva G, Nin-Hill A, Wirth U, Rustler K, Ranucci M, Opar E, et al. (October 2024). "Light-Activated Agonist-Potentiator of GABA_A Receptors for Reversible Neuroinhibition in Wildtype Mice". Journal of the American Chemical Society. doi:10.1021/jacs.4c08446. PMC 11503767. PMID 39383450.

harvard.edu

ui.adsabs.harvard.edu

Pinna G, Galici R, Schneider HH, Stephens DN, Turski L (March 1997). "Alprazolam dependence prevented by substituting with the beta-carboline abecarnil". Proceedings of the National Academy of Sciences of the United States of America. 94 (6): 2719–2723. Bibcode:1997PNAS...94.2719P. doi:10.1073/pnas.94.6.2719. PMC 20156. PMID 9122263.

nih.gov

pubmed.ncbi.nlm.nih.gov

Ozawa M, Nakada Y, Sugimachi K, Yabuuchi F, Akai T, Mizuta E, et al. (March 1994). "Pharmacological characterization of the novel anxiolytic beta-carboline abecarnil in rodents and primates". Japanese Journal of Pharmacology. 64 (3): 179–187. doi:10.1254/jjp.64.179. PMID 7912751.
Aufdembrinke B (1998). "Abecarnil, a new beta-carboline, in the treatment of anxiety disorders". The British Journal of Psychiatry. Supplement. 34 (34): 55–63. doi:10.1192/S0007125000293537. PMID 9829018. S2CID 24311570.
Pinna G, Galici R, Schneider HH, Stephens DN, Turski L (March 1997). "Alprazolam dependence prevented by substituting with the beta-carboline abecarnil". Proceedings of the National Academy of Sciences of the United States of America. 94 (6): 2719–2723. Bibcode:1997PNAS...94.2719P. doi:10.1073/pnas.94.6.2719. PMC 20156. PMID 9122263.
Jung ME, Wallis CJ, Gatch MB, Lal H (June 2000). "Abecarnil and alprazolam reverse anxiety-like behaviors induced by ethanol withdrawal". Alcohol. 21 (2): 161–168. doi:10.1016/S0741-8329(00)00079-3. PMID 10963939.
Krause W, Schütt B, Duka T (May 1990). "Pharmacokinetics and acute toleration of the beta-carboline derivative abecarnil in man". Arzneimittel-Forschung. 40 (5): 529–532. PMID 1974428.
Duka T, Schütt B, Krause W, Dorow R, McDonald S, Fichte K (April 1993). "Human studies on abecarnil a new beta-carboline anxiolytic: safety, tolerability and preliminary pharmacological profile". British Journal of Clinical Pharmacology. 35 (4): 386–394. doi:10.1111/j.1365-2125.1993.tb04155.x. PMC 1381549. PMID 8097921.
Stephens DN, Schneider HH, Kehr W, Andrews JS, Rettig KJ, Turski L, et al. (April 1990). "Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors". The Journal of Pharmacology and Experimental Therapeutics. 253 (1): 334–343. PMID 1970361.
Löscher W, Hönack D (April 1992). "Withdrawal precipitation by benzodiazepine receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant beta-carboline abecarnil". Naunyn-Schmiedeberg's Archives of Pharmacology. 345 (4): 452–460. doi:10.1007/BF00176624. PMID 1352384. S2CID 20486955.
Sannerud CA, Ator NA, Griffiths RR (October 1992). "Behavioral pharmacology of abecarnil in baboons: self-injection, drug discrimination and physical dependence". Behavioural Pharmacology. 3 (5): 507–516. doi:10.1097/00008877-199210000-00009. PMID 11224153. S2CID 32081258.
Ballenger JC, McDonald S, Noyes R, Rickels K, Sussman N, Woods S, et al. (1991). "The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder". Psychopharmacology Bulletin. 27 (2): 171–179. PMID 1681563.
Maleeva G, Nin-Hill A, Wirth U, Rustler K, Ranucci M, Opar E, et al. (October 2024). "Light-Activated Agonist-Potentiator of GABA_A Receptors for Reversible Neuroinhibition in Wildtype Mice". Journal of the American Chemical Society. doi:10.1021/jacs.4c08446. PMC 11503767. PMID 39383450.

ncbi.nlm.nih.gov

Pinna G, Galici R, Schneider HH, Stephens DN, Turski L (March 1997). "Alprazolam dependence prevented by substituting with the beta-carboline abecarnil". Proceedings of the National Academy of Sciences of the United States of America. 94 (6): 2719–2723. Bibcode:1997PNAS...94.2719P. doi:10.1073/pnas.94.6.2719. PMC 20156. PMID 9122263.
Duka T, Schütt B, Krause W, Dorow R, McDonald S, Fichte K (April 1993). "Human studies on abecarnil a new beta-carboline anxiolytic: safety, tolerability and preliminary pharmacological profile". British Journal of Clinical Pharmacology. 35 (4): 386–394. doi:10.1111/j.1365-2125.1993.tb04155.x. PMC 1381549. PMID 8097921.
Maleeva G, Nin-Hill A, Wirth U, Rustler K, Ranucci M, Opar E, et al. (October 2024). "Light-Activated Agonist-Potentiator of GABA_A Receptors for Reversible Neuroinhibition in Wildtype Mice". Journal of the American Chemical Society. doi:10.1021/jacs.4c08446. PMC 11503767. PMID 39383450.

semanticscholar.org

api.semanticscholar.org

Aufdembrinke B (1998). "Abecarnil, a new beta-carboline, in the treatment of anxiety disorders". The British Journal of Psychiatry. Supplement. 34 (34): 55–63. doi:10.1192/S0007125000293537. PMID 9829018. S2CID 24311570.
Löscher W, Hönack D (April 1992). "Withdrawal precipitation by benzodiazepine receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant beta-carboline abecarnil". Naunyn-Schmiedeberg's Archives of Pharmacology. 345 (4): 452–460. doi:10.1007/BF00176624. PMID 1352384. S2CID 20486955.
Sannerud CA, Ator NA, Griffiths RR (October 1992). "Behavioral pharmacology of abecarnil in baboons: self-injection, drug discrimination and physical dependence". Behavioural Pharmacology. 3 (5): 507–516. doi:10.1097/00008877-199210000-00009. PMID 11224153. S2CID 32081258.